FREE Account Opening + No Clearing Fees
Loading...

Akums Drugs and Pharmaceuticals IPO vs Orient Technologies IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Orient Technologies IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Orient Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
Logo Akums Drugs and Pharmaceuticals IPO Logo Orient Technologies IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers ICICI Securities Limited

Axis Bank Limited

Citigroup Global Markets India Private Limited

Ambit Private Limited
Elara Capital (India) Private Limited
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Orient Technologies IPO is up to ₹214.76 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Orient Technologies IPO is .

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹646.00 per share ₹195.00 per share
Issue Price (Upper) ₹679.00 per share ₹206.00 per share
Issue Price (Final) ₹679.00 per share
Discount (Retail)
Discount (Employee) ₹64.00 per share
Market Lot Size 22 shares 72 shares
Fresh Issue Size 1,00,14,727 shares 58,25,243 shares
Fresh Issue Size (Amount) up to ₹680.00 Cr up to ₹120.00 Cr
OFS Issue Size 1,73,30,435 shares 46,00,000 shares
OFS Issue Size (Amount) up to ₹1,176.74 Cr up to ₹94.76 Cr
Issue Size Total 2,73,45,162 shares 1,04,25,243 shares
Issue Size Total (Amount) up to ₹1,856.74 Cr up to ₹214.76 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Orient Technologies IPO opens on Aug 21, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Orient Technologies IPO is Aug 01, 2024, and Aug 23, 2024, respectively.

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
Anchor Bid Date Jul 29, 2024 Aug 19, 2024
Issue Open Jul 30, 2024 Aug 21, 2024
Issue Close Aug 01, 2024 Aug 23, 2024
Basis Of Allotment (Tentative) Aug 02, 2024 Aug 26, 2024
Initiation of Refunds (Tentative) Aug 05, 2024 Aug 27, 2024
Credit of Share (Tentative) Aug 05, 2024 Aug 27, 2024
Listing date (Tentative) Aug 06, 2024 Aug 28, 2024
Anchor Lockin End date 1 Sep 01, 2024 Sep 22, 2024
Anchor Lockin End date 2 Oct 31, 2024 Nov 21, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Orient Technologies IPO P/E ratio of 17.8.

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets3,516.373,266.533,069.05
Revenue4,212.213,700.933,694.52
Profit After Tax0.7997.82-250.87
Net Worth709.50717.19621.98
Reserves and Surplus861.01868.70787.79
Total Borrowing491.56536.97357.95
Amount in ₹ Crore

Orient Technologies Limited Financial Information (Restated)

Orient Technologies Limited's revenue increased by 12% and profit after tax (PAT) rose by 8% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 202231 Mar 2021
Assets311.14215.25176.32112.45
Revenue606.86542.01469.12248.96
Profit After Tax41.4538.333.490.13
Net Worth175.31128.8294.1161.29
Reserves and Surplus138.79111.3276.6144.79
Total Borrowing4.8212.862.289.22
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 84.94% 97.96%
Promoter Shareholding (Post-Issue)
P/E Ratio 17.8
Market Cap ₹0.00 Cr.
ROE 0.11%% 27.26%
ROCE 3.37%% 28.42%
Debt/Equity 0.69
EPS ₹11.57
RoNW -0.57% 23.64%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Orient Technologies IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and in Orient Technologies IPO.

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
Anchor Investor Reserveration 1,22,05,912 shares
Market Maker Reserveration
QIB 81,37,276 shares
NII 40,68,637 shares
RII 27,12,424 shares
Employee 2,43,902 shares
Others
Total 1,51,62,239 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Orient Technologies IPO subscribed .

  Akums Drugs and Pharmaceuticals IPO Orient Technologies IPO
QIB (times) 90.09x
NII (times) 42.10x
Big NII (times) 47.43x
Small NII (times) 31.45x
RII (times) 20.80x
Employee (times) 4.14x
Other (times)
Total (times) 63.44x

Comments

Add a public comment...